315 related articles for article (PubMed ID: 28126706)
1. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
[TBL] [Abstract][Full Text] [Related]
3. A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.
Friedli K; Almond M; Day C; Chilcot J; Gane Mda S; Davenport A; Guirguis A; Fineberg N; Spencer B; Wellsted D; Farrington K
BMC Nephrol; 2015 Oct; 16():172. PubMed ID: 26503099
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
8. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
10. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.
Mao JJ; Xie SX; Zee J; Soeller I; Li QS; Rockwell K; Amsterdam JD
Phytomedicine; 2015 Mar; 22(3):394-9. PubMed ID: 25837277
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
[TBL] [Abstract][Full Text] [Related]
12. Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.
Roest AM; Carney RM; Stein PK; Freedland KE; Meyer H; Steinmeyer BC; de Jonge P; Rubin EH
J Clin Psychiatry; 2012 Jan; 73(1):31-6. PubMed ID: 21903027
[TBL] [Abstract][Full Text] [Related]
13. Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.
Mehrotra R; Cukor D; Unruh M; Rue T; Heagerty P; Cohen SD; Dember LM; Diaz-Linhart Y; Dubovsky A; Greene T; Grote N; Kutner N; Trivedi MH; Quinn DK; Ver Halen N; Weisbord SD; Young BA; Kimmel PL; Hedayati SS
Ann Intern Med; 2019 Mar; 170(6):369-379. PubMed ID: 30802897
[TBL] [Abstract][Full Text] [Related]
14. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Banerjee S; Hellier J; Romeo R; Dewey M; Knapp M; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
Health Technol Assess; 2013 Feb; 17(7):1-166. PubMed ID: 23438937
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
Gao L; Wu C; Liao Y; Wang J
J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
[TBL] [Abstract][Full Text] [Related]
16. Nepeta menthoides Boiss. & Buhse freeze-dried aqueous extract versus sertraline in the treatment of major depression: A double blind randomized controlled trial.
Kolouri S; Firoozabadi A; Salehi A; Zarshenas MM; Dastgheib SA; Heydari M; Rezaeizadeh H
Complement Ther Med; 2016 Jun; 26():164-70. PubMed ID: 27261997
[TBL] [Abstract][Full Text] [Related]
17. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial.
Forlenza OV; Almeida OP; Stoppe A; Hirata ES; Ferreira RCR
Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
